122 related articles for article (PubMed ID: 10560357)
1. Microsatellite abnormalities in plasma of patients with breast carcinoma: concordance with the primary tumour.
Mayall F; Fairweather S; Wilkins R; Chang B; Nicholls R
J Clin Pathol; 1999 May; 52(5):363-6. PubMed ID: 10560357
[TBL] [Abstract][Full Text] [Related]
2. A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer.
Schwarzenbach H; Müller V; Beeger C; Gottberg M; Stahmann N; Pantel K
Breast Cancer Res; 2007; 9(5):R66. PubMed ID: 17915011
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite alterations plasma DNA of primary breast cancer patients.
Shaw JA; Smith BM; Walsh T; Johnson S; Primrose L; Slade MJ; Walker RA; Coombes RC
Clin Cancer Res; 2000 Mar; 6(3):1119-24. PubMed ID: 10741742
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity in serial plasma DNA samples during follow-up of women with breast cancer.
Wang Q; Larson PS; Schlechter BL; Zahid N; Finnemore E; de las Morenas A; Blanchard RA; Rosenberg CL
Int J Cancer; 2003 Oct; 106(6):923-9. PubMed ID: 12918071
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite analysis of breast carcinoma and corresponding local recurrences.
Regitnig P; Moser R; Thalhammer M; Luschin-Ebengreuth G; Ploner F; Papadi H; Tsybrovskyy O; Lax SF
J Pathol; 2002 Oct; 198(2):190-7. PubMed ID: 12237878
[TBL] [Abstract][Full Text] [Related]
6. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H; Müller V; Stahmann N; Pantel K
Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
[TBL] [Abstract][Full Text] [Related]
7. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.
Chen X; Bonnefoi H; Diebold-Berger S; Lyautey J; Lederrey C; Faltin-Traub E; Stroun M; Anker P
Clin Cancer Res; 1999 Sep; 5(9):2297-303. PubMed ID: 10499596
[TBL] [Abstract][Full Text] [Related]
8. Detection of tumor DNA in plasma using whole genome amplification.
Nakamoto D; Yamamoto N; Takagi R; Katakura A; Mizoe JE; Shibahara T
Bull Tokyo Dent Coll; 2006 Aug; 47(3):125-31. PubMed ID: 17344620
[TBL] [Abstract][Full Text] [Related]
9. [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma].
Pang JZ; Qin LX; Ren N; Ye QH; Ying WD; Liu YK; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1662-5. PubMed ID: 16854315
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability in breast cancer.
Rush EB; Calvano JE; van Zee KJ; Zelenetz AD; Borgen PI
Ann Surg Oncol; 1997 Jun; 4(4):310-5. PubMed ID: 9181230
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at tumor suppressor genes detectable on fractionated circulating cell-free tumor DNA as indicator of breast cancer progression.
Schwarzenbach H; Eichelser C; Kropidlowski J; Janni W; Rack B; Pantel K
Clin Cancer Res; 2012 Oct; 18(20):5719-30. PubMed ID: 23014523
[TBL] [Abstract][Full Text] [Related]
12. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
13. Mutations of p53 gene can be detected in the plasma of patients with large bowel carcinoma.
Mayall F; Jacobson G; Wilkins R; Chang B
J Clin Pathol; 1998 Aug; 51(8):611-3. PubMed ID: 9828821
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
Schwarzenbach H; Chun FK; Müller I; Seidel C; Urban K; Erbersdobler A; Huland H; Pantel K; Friedrich MG
BJU Int; 2008 Jul; 102(2):253-8. PubMed ID: 18336598
[TBL] [Abstract][Full Text] [Related]
15. Variability in the interpretation of microsatellite patterns with different electrophoretic conditions.
Santos AC; Yamaoka Y; Graham DY; Sepulveda AR
Mol Pathol; 1999 Oct; 52(5):302-4. PubMed ID: 10748882
[TBL] [Abstract][Full Text] [Related]
16. Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations.
Silva JM; Dominguez G; Garcia JM; Gonzalez R; Villanueva MJ; Navarro F; Provencio M; San Martin S; España P; Bonilla F
Cancer Res; 1999 Jul; 59(13):3251-6. PubMed ID: 10397273
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability in early sporadic breast cancer.
Shaw JA; Walsh T; Chappell SA; Carey N; Johnson K; Walker RA
Br J Cancer; 1996 Jun; 73(11):1393-7. PubMed ID: 8645585
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.
Feilotter HE; Coulon V; McVeigh JL; Boag AH; Dorion-Bonnet F; Duboué B; Latham WC; Eng C; Mulligan LM; Longy M
Br J Cancer; 1999 Feb; 79(5-6):718-23. PubMed ID: 10070859
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific DNA in plasma of breast cancer patients.
Shao ZM; Nguyen M
Anticancer Drugs; 2002 Apr; 13(4):353-7. PubMed ID: 11984080
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance.
Gonzalez R; Silva JM; Sanchez A; Dominguez G; Garcia JM; Chen XQ; Stroun M; Provencio M; España P; Anker P; Bonilla F
Ann Oncol; 2000 Sep; 11(9):1097-104. PubMed ID: 11061602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
